Study: PrEP, Taken Regularly, 100 Percent Effective

By BTL Staff

Scientists at the International AIDS Conference in Sydney, Australia, released the results of an open label study of Pre-Exposure Prophylaxis this week, which found that regular dosing of the drug Truvada is 100 percent effective in preventing HIV-negative people from becoming infected with the virus.

AIDS Map reports the study, released in The Lancelet medical journal in conjunction with the report on the study at the conference, found that people who had blood concentration levels equivalent to taking Truvada at least four times a week. That, researchers say, resulted in 100 percent protection from HIV infection.

The study did find adherence to taking the drugs was low - only one-third of participants had a blood level equal to four or more weekly doses. Adherence was also lower in younger men who have sex with men, a key demographic in need of the drug, experts from both the CDC and the World Health Organization have said.

Learn more at http://www.prep4itnow.com


  • Latest News

Enter To Win

Enter contests to win great prizes like CDs, DVDs, concert tickets and more

Special Section: Automotive
Former Chrysler Executive Talks Workplace Inclusivity

As an openly gay man, Fred Hoffman said, "I really didn't know if there would be an issue." And while he wasn't waving rainbow flags when he was recruited by Chrysler in 1988, he was told being gay wasn't a problem.

View More Automotive
This Week's Issue

Download or view this week's print issue today!